← Compounds
NAD+
peptide · headline503A compoundedServes as a coenzyme in redox reactions facilitating ATP production
Summary
NAD+ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme involved in redox reactions, DNA repair, and energy metabolism. NAD+ precursors and NAD+ IV/IM formulations are studied for their effects on aging, mitochondrial health, and cellular stress.
How it works
- Serves as a coenzyme in redox reactions facilitating ATP production
- Acts as a substrate for sirtuins and PARPs
- Regulates circadian rhythms and immune responses
- Maintains NAD+/NADH and NADP+/NADPH redox balance
- Activates PGC-1α through SIRT1, promoting mitochondrial biogenesis
- Supports antioxidant response via FOXO and NRF2 activation
Dosing
- unit: mglow dose: 250frequency: dailyhigh dose: 1000standard dose: 500administration route: Oral
- unit: mglow dose: 250frequency: once weeklyhigh dose: 1000standard dose: 500administration route: Intravenous (IV)
- unit: mglow dose: 25frequency: 1-3 times per weekhigh dose: 100standard dose: 50administration route: Subcutaneous (SQ)
Cycling
- 25 mg - 100 mg 1–3 times per week as per Dr. Jatoi protocol
Side effects
common: ["Insomnia, anxiety, or fatigue if escalated too quickly; gradual titration advised","Transient headache or flushing (dose-dependent)","Doses exceeding 200–300 mg/day reserved for supervised use"]
Chemistry & PK
half life: 1-2 hours
degradation: Metabolized by conversion to NADH as part of the cellular redox reactions
molecular weight: 663.43
molecular formula: C21H27N7O14P2
tissue specificity: Mitochondria
Verified citations
2 · PubMed-checked- NAD+ in aging, metabolism, and neurodegeneration.reviewPMID 26785480 ↗
- NAD+ and sirtuins in aging and disease.reviewPMID 24786309 ↗
Used for
Legal / compounding
503A compounded
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.